- Fee assured
- Awaiting verification
- General cardiology
- Interventional cardiology
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust and a clinical academic at Imperial College London. She has expertise in general and interventional cardiology. She is a clinical trialist and her research interests are in coronary intervention, coronary physiology and invasive intravascular assessment.
Dr Al-Lamee is a world leading academic in cardiovascular research with a focus on clinical trials that impact the care of patients with coronary artery disease. She believes in the rigorous testing of clinical practice and the use of evidence-based medicine in all aspects of medical care.
Dr Al-Lamee performs coronary angiography, complex coronary angioplasty and pacemaker implantation at the Hammersmith Hospital. She leads the cardiac rehabilitation service at Imperial NHS Trust in Ealing.
She designed, conducted and led the ORBITA trial. This is one of the most widely cited clinical trials in cardiology of this decade and investigated the use of coronary angioplasty in treating stable coronary artery disease. She is lead author of the primary publication in The Lancet and the secondary publication in Circulation.
At Imperial College London she is actively involved in the development and recruitment for a number of multi-centre international clinical trials. Dr Al-Lamee has over 50 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career.
Dr Al-Lamee is an Imperial College tutor with regular undergraduate and postgraduate teaching commitments. She enjoys training the next generation of researchers and doctors. She is a PhD and BSc supervisor to a number of students. She teaches on advanced coronary physiology and imaging courses worldwide.
Dr Al-Lamee studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006.
Dr Al-Lamee has thirteen years of clinical Cardiology experience. She completed three years of Interventional Fellowship training at Hammersmith Hospital in London and spent a year training in complex intervention under the supervision of Professor Antonio Colombo in Milan. She qualified as a consultant cardiologist in 2013. She was awarded a PhD from Imperial College London in 2018.
Areas of interest
General cardiology; interventional cardiology; angina; heart attack; coronary angiogram; coronary angioplasty
Current NHS consultant posts held
Interventional cardiology consultant
Imperial College Healthcare NHS Trust
Imperial College London
Dr Al-Lamee is a clinical trialist who tests cardiovascular practice in large multi-centre clinical research trials. She has published her research in some of the world’s highest impact scientific journals including The Lancet. She has presented her work as late breaking clinical trials in the largest international cardiovascular scientific congresses.
(Additional) Languages spoken
- Arabic - Native or bilingual
1. Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA investigators
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
2. Al-Lamee R, Howard JP, Shun-Shin MJ, Thompson D, Dehbi HM, Sen S, Nijjer S, Petraco R, Davies J, Keeble T, Tang K, Malik IS, Cook C, Ahmad Y, Sharp ASP, Gerber R, Baker C, Kaprielian R, Talwar S, Assomull R, Cole G, Keenan NG, Kanaganayagam G, Sehmi J, Wensel R, Harrell FE, Mayet J, Thom SA, Davies JE, Francis DP
Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel coronary artery disease: physiology-stratified analysis of ORBITA.
3. Al-Lamee R, Shun-Shin MJ, Howard JP, Nowbar AN, Rajkumar C, Thompson D, Sen S, Nijjer S, Petraco R, Davies J, Keeble T, Tang K, Malik IS, Bual N, Cook C, Ahmad Y, Seligman H, Sharp ASP, Gerber R, Talwar S, Assomull R, Cole G, Keenan NG, Kanaganayagam G, Sehmi J, Wensel R, Harrell FE, Mayet J, Thom SA, Davies JE, Francis DP
Dobutamine stress echocardiography as a predictor of the placebo-controlled response to percutaneous coronary intervention in stable coronary artery disease: the stress echocardiography-stratified analysis of ORBITA.
Circulation. 2019 Dec 10; 140(24): 1971-1980
Reference number 6057129
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.